檢索結果 - Weigel, Brenda

Killing the Killer: Natural Killer Cells to Treat Ewing’s Sarcoma 由 Ahn, Yong-Oon, Weigel, Brenda, Verneris, Michael R.

獲取全文 獲取全文 獲取全文

Prognostic Factors for Development of Subsequent Metastases in Localized Osteosarcoma: A Systematic Review and Identification of Literature Gaps 由 Basile, Patrick, Greengard, Emily, Weigel, Brenda, Spector, Logan

獲取全文 獲取全文 獲取全文

3488 A comparison between the Rolling 6 and 3+3 dose escalation study designs for phase 1 clinical trials 由 Minard, Charles Gene, Rau, Rachel, Hilsenbeck, Susan, Weigel, Brenda J., Fox, Elizabeth, Adamson, Peter, Blaney, Susan

獲取全文 獲取全文

Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis 由 Diessner, Brandon J., Weigel, Brenda J., Murugan, Paari, Zhang, Lin, Poynter, Jenny N., Spector, Logan G.

獲取全文 獲取全文 獲取全文

Racial and ethnic differences in sarcoma incidence are independent of census-tract socioeconomic status. 由 Diessner, Brandon J., Weigel, Brenda J., Murugan, Paari, Zhang, Lin, Poynter, Jenny N., Spector, Logan G.

獲取全文 獲取全文 獲取全文

Phase 2 trial of Sorafenib in Children and Young Adults with Refractory Solid Tumors: A Report from the Children’s Oncology Group 由 Kim, AeRang, Widemann, Brigitte C., Krailo, Mark, Jayaprakash, Nalini, Fox, Elizabeth, Weigel, Brenda, Blaney, Susan M.

獲取全文 獲取全文 獲取全文

Prolonged Subcutaneous Administration of 852A, a Novel Systemic Toll-like Receptor 7 Agonist, to Activate Innate Immune Responses in Patients with Advanced Hematologic Malignancies 由 Weigel, Brenda J., Cooley, Sarah, DeFor, Todd, Weisdorf, Daniel J., Panoskaltsis-Mortari, Angela, Chen, Wei, Blazar, Bruce R., Miller, Jeffrey S.

獲取全文 獲取全文 獲取全文

First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot... 由 Balis, Frank M., Thompson, Patrick A., Mosse, Yael P., Blaney, Susan M., Minard, Charles G., Weigel, Brenda J., Fox, Elizabeth

獲取全文 獲取全文 獲取全文

Historical time-to-progression (TTP) and progression-free survival (PFS) in relapsed/refractory neuroblastoma modern-era (2002-14) patients from Children’s Oncology Group (COG) ear... 由 London, Wendy B, Bagatell, Rochelle, Weigel, Brenda J, Fox, Elizabeth, Guo, Dongjing, Van Ryn, Collin, Naranjo, Arlene, Park, Julie R

獲取全文 獲取全文 獲取全文

A Phase 1 Study of Prexasertib (LY2606368), a CHK1/2 Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors: A Report from the Children’s... 由 Cash, Thomas, Fox, Elizabeth, Liu, Xiaowei, Minard, Charles G., Reid, Joel M., Scheck, Adrienne C., Weigel, Brenda J., Wetmore, Cynthia

獲取全文 獲取全文 獲取全文

Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma(,) 由 Charbonneau, Bridget, Vogel, Rachel Isaksson, Manivel, J. Carlos, Rizzardi, Anthony, Schmechel, Stephen C., Ognjanovic, Simona, Subramanian, Subbaya, Largaespada, David, Weigel, Brenda

獲取全文 獲取全文 獲取全文

Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children’s Oncology Group 由 Gupta, Abha A., Chi, Yueh-Yun, Anderson, James R., Lyden, Elizabeth, Weigel, Brenda, Arndt, Carola, Meyer, William H., Rosenberg, Abby, Hawkins, Douglas S.

獲取全文 獲取全文 獲取全文

Identification of aggressive Gardner syndrome phenotype associated with a de novo APC variant, c.4666dup 由 Kiessling, Patrick, Dowling, Eric, Huang, Yajue, Ho, Mai Lan, Balakrishnan, Karthik, Weigel, Brenda J., Highsmith, W. Edward, Niu, Zhiyv, Schimmenti, Lisa A.

獲取全文 獲取全文 獲取全文

Phase I Trial of Seneca Valley Virus (NTX-010) in Children with Relapsed / Refractory Solid Tumors: A Report of the Children’s Oncology Group 由 Burke, Michael J., Ahern, Charlotte, Weigel, Brenda J., Poirier, John T., Rudin, Charles M., Chen, Yingbei, Cripe, Timothy, Bernhardt, M. Brooke, Blaney, Susan M.

獲取全文 獲取全文 獲取全文

Toxicity and Pharmacokinetics of Actinomycin- D and Vincristine in Children and Adolescents: Children’s Oncology Group Study ADVL06B1. 由 Skolnik, Jeffrey, Hall, David, Barkauskas, Donald A., Moorthy, Ganesh, Larson, Thomas R., Fox, Elizabeth, Weigel, Brenda J., Berg, Stacey L., Reid, Joel M.

獲取全文 獲取全文 獲取全文

A Phase I Study of Entinostat in Children and Adolescents with Recurrent or Refractory Solid Tumors, Including CNS Tumors: Trial ADVL1513, Pediatric Early Phase-Clinical Trial Netw... 由 Bukowinski, Andrew, Chang, Bill, Reid, Joel M., Liu, Xiaowei, Minard, Charles G., Trepel, Jane B., Lee, Min-Jung, Fox, Elizabeth, Weigel, Brenda J.

獲取全文 獲取全文 獲取全文

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD) 由 Taylor, Patricia A., Ehrhardt, Michael J., Lees, Christopher J., Tolar, Jakub, Weigel, Brenda J., Panoskaltsis-Mortari, Angela, Serody, Jonathan S., Brinkmann, Volker, Blazar, Bruce R.

獲取全文 獲取全文 獲取全文

A Therapeutic Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) 由 Burke, Michael J., Lamba, Jatinder K, Pounds, Stanley, Cao, Xueyuan, Ghodke-Puranaik, Yogita, Lindgren, Bruce R., Weigel, Brenda J., Verneris, Michael R., Miller, Jeffrey S.

獲取全文 獲取全文 獲取全文

Phase II Study of Cixutumumab in Combination with Temsirolimus in Pediatric Patients and Young Adults with Recurrent or Refractory Sarcoma: A Report from the Children’s Oncology Gr... 由 Wagner, Lars M., Fouladi, Maryam, Ahmed, Atif, Krailo, Mark D., Weigel, Brenda, DuBois, Steven G., Doyle, L. Austin, Chen, Helen, Blaney, Susan M.

獲取全文 獲取全文 獲取全文

Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With Hig... 由 Weigel, Brenda J., Lyden, Elizabeth, Anderson, James R., Meyer, William H., Parham, David M., Rodeberg, David A., Michalski, Jeff M., Hawkins, Douglas S., Arndt, Carola A.S.

獲取全文 獲取全文 獲取全文